Mechanism of Xenopus Cranial Neural Crest Cell Migration
非洲爪蟾颅神经嵴细胞迁移机制
基本信息
- 批准号:7575150
- 负责人:
- 金额:$ 32.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnteriorAntisense OligonucleotidesAsthmaCell AdhesionCell DeathCell ProliferationCell surfaceCellsCephalicCleaved cellDataDevelopmentDiagnosisDisintegrinsDominant-Negative MutationDrug usageEmbryoEmbryonic DevelopmentEnvironmentEpidermisEventExtracellular MatrixFaceFibronectinsHistone H3HumanImmigrationIn Situ HybridizationIn Situ Nick-End LabelingIn VitroInjection of therapeutic agentJawLabelLateralLeadLightLinkMeasuresMesodermMessenger RNAMetalloproteasesModelingNeoplasm MetastasisNeural CrestNeural Crest CellOligonucleotidesPathway interactionsPeptide HydrolasesPeripheral Nervous SystemPhenotypePhosphorylationPositioning AttributeProteinsRelative (related person)Research PersonnelSignal TransductionSiteStructureTestingTissuesTranslationsWorkXenopusadhesion receptorbasecell motilitycraniofacialin vitro testingin vivoinhibitor/antagonistmigrationneural platenoveloverexpressionpreventprogramsprotein functionresearch studytumor
项目摘要
Proper cranial neural crest (CNC) cell migration is essential for the construction of the face, jaws and their
peripheral nervous system connections. Despite this importance, little is known about how neural crest cell
migration is regulated. During Xenopus embryo development the expression of ADAM13 (a protein
containing A Disintegrin And Metalloprotease) correlates with the migration of the cranial neural crest cells
from the lateral border of the neural plate to the ventral anterior station where they eventually form facial
structures (Alfandari et al.,1997). Our on-going analyses of cranial neural crest cells expressing a dominant
negative form of ADAM13 suggest that ADAM13 promotes and/or directs their migration in two of the three
possible pathways. Our working hypothesis is that ADAM13 cleaves a protein that normally restricts cranial
neural crest cell migration. This protein may either be inserted in the migration path as a stop signal to
prevent cell passage or be expressed at the cranial neural crest cell surface to hold the cells in place as an
anchor. To test these hypotheses and analyze whether other ADAM and related metalloproteases may also
be involved in cranial neural crest cell migration we propose the following specific Aims. This proposal has
three Aims to understand 1) if cells missing ADAM13 protein can use other ADAM and related
metalloprotease to migrate, 2) if ADAM13 functions as a "drill" to open migration pathways, 3) if ADAM13
cuts an anchor that attaches cranial neural crest cells to their environment. Using specific morpholino
oligonucleotides, we can prevent translation of ADAM proteins including ADAM13 in embryos and test how
cranial neural crest cells migrate. This can be compared to the migration of cells in which ADAM13 function
is blocked (using drug inhibitor). Using grafts we will test whether cranial neural crest cells missing ADAM13
activity can follow cells that have ADAM13. Finally, we will test if ADAM13 can cleave proteins that are
known to anchor cells down. The proposed studies will increase our understanding of events that govern
normal formation of the face, an essential step towards diagnosing and treating conditions that lead to
abnormal development. Furthermore, information about ADAM contributions to cell migration could lead to
new understanding of the function of these proteins in various cancer and metastasis. In particular these
protein (ADAM) are likely to be involved in the escape of cells from the original tumor to new sites.
适当的颅神经嵴(CNC)细胞迁移对于面部、颌骨及其周围组织的构建至关重要。
周围神经系统连接尽管如此重要,但人们对神经嵴细胞如何
移民受到管制。在非洲爪蟾胚胎发育过程中,
含有去整合素和金属蛋白酶)与颅神经嵴细胞的迁移相关
从神经板的外侧边缘到腹前站,在那里它们最终形成面部
结构(Alfandari等人,1997年)。我们正在进行的颅神经嵴细胞的分析,
ADAM 13的阴性形式表明,ADAM 13促进和/或指导它们在三种中的两种中的迁移。
可能的路径。我们的工作假设是,ADAM 13切割一种蛋白质,通常限制颅
神经嵴细胞迁移这种蛋白质可以作为停止信号插入迁移路径中,
阻止细胞通过或在颅神经嵴细胞表面表达,以将细胞保持在适当位置,
锚。为了验证这些假设,并分析其他ADAM和相关金属蛋白酶是否也可能
参与颅神经嵴细胞迁移,我们提出以下具体目的。这一建议
三个目的了解1)如果细胞缺失ADAM 13蛋白,可以使用其他ADAM和相关
金属蛋白酶迁移,2)如果ADAM 13作为“钻”打开迁移途径,3)如果ADAM 13
切断了一个将颅神经嵴细胞与周围环境相连的锚。使用特定的吗啉代
寡核苷酸,我们可以阻止胚胎中包括ADAM 13在内的ADAM蛋白的翻译,并测试如何
颅神经嵴细胞迁移。这可以与其中ADAM 13起作用的细胞的迁移相比较
被阻断(使用药物抑制剂)。使用移植物,我们将测试缺失ADAM 13的颅神经嵴细胞是否
活动可以跟随具有ADAM 13的细胞。最后,我们将测试ADAM 13是否可以切割蛋白质,
已知它能将细胞锚下来。拟议中的研究将增加我们对统治事件的理解,
面部的正常形成,这是诊断和治疗导致
异常发育此外,关于ADAM对细胞迁移的贡献的信息可能导致
这些蛋白质在各种癌症和转移中的功能的新认识。特别是这些
蛋白(ADAM)可能参与细胞从原始肿瘤逃逸到新部位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOMINIQUE R ALFANDARI其他文献
DOMINIQUE R ALFANDARI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOMINIQUE R ALFANDARI', 18)}}的其他基金
Production and characterization of monoclonal antibodies to Xenopus Proteins
非洲爪蟾蛋白单克隆抗体的生产和表征
- 批准号:
9208974 - 财政年份:2017
- 资助金额:
$ 32.8万 - 项目类别:
Production and characterization of monoclonal antibodies to Xenopus Proteins
非洲爪蟾蛋白单克隆抗体的生产和表征
- 批准号:
9897195 - 财政年份:2017
- 资助金额:
$ 32.8万 - 项目类别:
Mechanism of Xenopus Cranial Neural Crest Cell Migration
非洲爪蟾颅神经嵴细胞迁移机制
- 批准号:
7091251 - 财政年份:2006
- 资助金额:
$ 32.8万 - 项目类别:
相似海外基金
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
- 批准号:
10677284 - 财政年份:2023
- 资助金额:
$ 32.8万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10464020 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Strategy for specific delivery of antisense oligonucleotides to T cells
将反义寡核苷酸特异性递送至 T 细胞的策略
- 批准号:
10547347 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10806783 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10689248 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10501862 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10623180 - 财政年份:2022
- 资助金额:
$ 32.8万 - 项目类别:
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
- 批准号:
BB/V019848/1 - 财政年份:2021
- 资助金额:
$ 32.8万 - 项目类别:
Research Grant